Specific Targeting of Caspase-9/PP2A Interaction as Potential New Anti-Cancer Therapy-Reference-Cited by-同舟云学术

Specific Targeting of Caspase-9/PP2A Interaction as Potential New Anti-Cancer Therapy

Published:2013-04-23 Issue:4 Volume:8 Page:e60816
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Arrouss Issam,Nemati Fariba,Roncal Fernando,Wislez Marie,Dorgham Karim,Vallerand David,Rabbe Nathalie,Karboul Narjesse,Carlotti Françoise,Bravo Jeronimo,Mazier Dominique,Decaudin Didier,Rebollo Angelita

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference50 articles.

1. Dual-specificity phosphatases as targets for antineoplastic agents;MA Lyon;Nat Rev Drug Discov,2002

2. [Renin-secreting tumour: about a new diagnosed case during pregnancy];F Ducret;Nephrol Ther,2005

3. Lipid phosphatases as drug discovery targets for type 2 diabetes;DF Lazar;Nat Rev Drug Discov,2006

4. Protein tyrosine phosphatases: from genes, to function, to disease;NK Tonks;Nat Rev Mol Cell Biol,2006

5. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes;J Liu;Cell,1991

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A translational study for biomarker identification of PEP-010, a pro-apoptotic peptide restoring apoptosis in cancer models;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2025-01

2. The first-in-class pro-apoptotic peptide PEP-010 is effective in monotherapy and in combination with paclitaxel on resistant ovarian adenocarcinoma cell models;Frontiers in Pharmacology;2024-08-07

3. Advancement and application of novel cell-penetrating peptide in cancer management;3 Biotech;2023-06-13

4. Regulatory miRNAs in cancer cell recovery from therapy exposure and its implications as a novel therapeutic strategy for preventing disease recurrence;The Enzymes;2023

5. Binding and Kinetic Analysis of Human Protein Phosphatase PP2A Interactions with Caspase 9 Protein and the Interfering Peptide C9h;Pharmaceutics;2022-09-27